News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
189,355 Results
Type
Article (11631)
Company Profile (94)
Press Release (177630)
Multimedia
Podcasts (28)
Webinars (5)
Section
Business (53280)
Career Advice (134)
Deals (8371)
Drug Delivery (18)
Drug Development (37158)
Employer Resources (18)
FDA (4643)
Job Trends (4756)
News (99953)
Policy (6943)
Tag
Academia (687)
Academic (1)
Accelerated approval (4)
Adcomms (14)
Allergies (87)
Alliances (15519)
ALS (40)
Alzheimer's disease (386)
Antibody-drug conjugate (ADC) (140)
Approvals (4715)
Artificial intelligence (134)
Autoimmune disease (22)
Automation (4)
Bankruptcy (62)
Best Places to Work (4385)
BIOSECURE Act (1)
Biosimilars (82)
Biotechnology (80)
Bladder cancer (81)
Brain cancer (34)
Breast cancer (326)
Cancer (2546)
Cardiovascular disease (36)
Career advice (119)
Career pathing (3)
CAR-T (134)
CDC (8)
Cell therapy (324)
Cervical cancer (18)
Clinical research (31007)
Collaboration (559)
Company closure (1)
Compensation (217)
Complete response letters (9)
COVID-19 (1060)
CRISPR (24)
C-suite (162)
Cystic fibrosis (16)
Data (1760)
Decentralized trials (1)
Denatured (5)
Depression (8)
Diabetes (67)
Diagnostics (2245)
Digital health (4)
Diversity (1)
Diversity, equity & inclusion (6)
Drug discovery (68)
Drug pricing (22)
Drug shortages (3)
Duchenne muscular dystrophy (53)
Earnings (19235)
Editorial (10)
Employer branding (3)
Employer resources (19)
Events (34481)
Executive appointments (364)
FDA (5379)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (326)
Gene editing (42)
Generative AI (9)
Gene therapy (124)
GLP-1 (174)
Government (890)
Grass and pollen (6)
Guidances (76)
Healthcare (5854)
HIV (14)
Huntington's disease (6)
IgA nephropathy (39)
Immunology and inflammation (150)
Immuno-oncology (14)
Indications (32)
Infectious disease (1146)
Inflammatory bowel disease (83)
Inflation Reduction Act (6)
Influenza (30)
Intellectual property (46)
Interviews (19)
IPO (4328)
IRA (15)
Job creations (643)
Job search strategy (109)
Kidney cancer (14)
Labor market (6)
Layoffs (165)
Leadership (3)
Legal (695)
Liver cancer (56)
Longevity (2)
Lung cancer (366)
Lymphoma (168)
Machine learning (5)
Management (5)
Manufacturing (107)
MASH (12)
Medical device (1232)
Medtech (1232)
Mergers & acquisitions (4295)
Metabolic disorders (141)
Multiple sclerosis (52)
NASH (1)
Neurodegenerative disease (39)
Neuropsychiatric disorders (7)
Neuroscience (623)
NextGen: Class of 2025 (1368)
Non-profit (822)
Now hiring (15)
Obesity (58)
Opinion (57)
Ovarian cancer (94)
Pain (15)
Pancreatic cancer (104)
Parkinson's disease (65)
Partnered (3)
Patents (95)
Patient recruitment (82)
Peanut (51)
People (17713)
Pharmaceutical (18)
Pharmacy benefit managers (3)
Phase I (11539)
Phase II (13408)
Phase III (9793)
Pipeline (885)
Policy (45)
Postmarket research (765)
Preclinical (4078)
Press Release (21)
Prostate cancer (121)
Psychedelics (4)
Radiopharmaceuticals (181)
Rare diseases (119)
Real estate (1055)
Recruiting (7)
Regulatory (6411)
Reports (12)
Research institute (1058)
Resumes & cover letters (14)
RNA editing (3)
RSV (33)
Schizophrenia (32)
Series A (67)
Series B (30)
Service/supplier (1)
Sickle cell disease (22)
Special edition (2)
Spinal muscular atrophy (21)
Sponsored (9)
Startups (1061)
State (1)
Stomach cancer (11)
Supply chain (16)
Tariffs (8)
The Weekly (23)
Vaccines (458)
Venture capital (21)
Weight loss (29)
Women's health (3)
Date
Today (51)
Last 7 days (207)
Last 30 days (734)
Last 365 days (12758)
2025 (7441)
2024 (14356)
2023 (15967)
2022 (19738)
2021 (19748)
2020 (16817)
2019 (12069)
2018 (8963)
2017 (10134)
2016 (9074)
2015 (10049)
2014 (6763)
2013 (4787)
2012 (4962)
2011 (5103)
2010 (4719)
Location
Africa (132)
Alabama (26)
Alaska (1)
Arizona (40)
Arkansas (4)
Asia (14247)
Australia (2216)
California (3363)
Canada (800)
China (447)
Colorado (96)
Connecticut (125)
Delaware (155)
Europe (30865)
Florida (399)
Georgia (61)
Idaho (13)
Illinois (244)
India (15)
Indiana (96)
Iowa (9)
Japan (144)
Kansas (16)
Kentucky (14)
Louisiana (1)
Maine (6)
Maryland (421)
Massachusetts (2524)
Michigan (25)
Minnesota (96)
Missouri (14)
Montana (14)
Nebraska (4)
Nevada (36)
New Hampshire (8)
New Jersey (1052)
New Mexico (6)
New York (822)
North Carolina (260)
North Dakota (8)
Northern California (1536)
Ohio (74)
Oklahoma (1)
Oregon (9)
Pennsylvania (539)
Rhode Island (12)
South America (164)
South Carolina (2)
Southern California (1367)
Tennessee (29)
Texas (522)
United States (11200)
Utah (61)
Virginia (44)
Washington D.C. (13)
Washington State (307)
Wisconsin (25)
189,355 Results for "kineta immuno oncology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cancer
The Search for the Next Keytruda: Immuno-Oncology’s Next Play
More than a decade after Merck’s Keytruda and BMS’ Yervoy ushered in the immuno-oncology revolution, the space is at a crossroads, with experts highlighting novel targets, combinations and pre-emptive immunization as the next wave for IO.
March 3, 2025
·
7 min read
·
Heather McKenzie
Press Releases
Immuno-Oncology Drugs Market Attains at USD 109.39 Billion in 2025
July 23, 2025
·
1 min read
Press Releases
BriaCell’s Subsidiary, BriaPro, Files Patent Application for Immuno-Oncology Platform with Novel Multitargeting Agents
July 30, 2025
·
5 min read
Business
TIGIT Turmoil: How Pharma Burned Billions on Failed Immuno-Oncology Projects
Leading companies spent $1.4 billion upfront on licensing deals and embarked on vast R&D programs. Clinical setbacks mean many companies are unlikely to ever recoup their investments.
June 25, 2025
·
5 min read
·
Nick Paul Taylor
Press Releases
HanchorBio and Henlius Sign Major Licensing Deal for HCB101 to Expand Global Immuno-Oncology Reach
July 1, 2025
·
4 min read
Drug pricing
Immuno-Oncology Stars Keytruda, Opdivo Likely To Come Into IRA Crosshairs
Leerink Partners previews the drugs likely to be subject to the Inflation Reduction Act’s next price negotiations as the program expands to Medicare Part B and smaller biotechs.
May 28, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
OSE Immunotherapeutics strengthens Growth Strategy: Accelerates key pillars of Inflammation and Immuno-Oncology
June 4, 2025
·
9 min read
Press Releases
Immuno-Oncology Drugs Market Forecast to Hit USD 32.32 Billion in 2025 Amid Rising Cancer Incidence
June 18, 2025
·
1 min read
Drug Development
Kineta to Present Preclinical Data on VISTA Blocking KVA12123 at Immuno US 2023
Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today that it will present at the Oxford Global Immuno US 2023, to be held on October 12-13, 2023 in San Diego, CA.
October 9, 2023
·
1 min read
Press Releases
PODO Therapeutics Unveils Predictive Platform for Immuno-Oncology and Radiation Sensitivity at AACR 2025
April 16, 2025
·
2 min read
1 of 18,936
Next
